 鲜花( 85)  鸡蛋( 2)
|

楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval
+ F j& N% B0 v, L$ d: j / U8 z! @' t% n2 M" b' m
EDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.+ r$ G( v0 p) P- Q
! D9 o% w+ ? q3 |5 {7 ?BY THE EDMONTON JOURNAL FEBRUARY 16, 2007
5 M# ~/ w3 c* u
* F; I3 _5 b' K
6 V$ p3 y9 u h7 e1 N- aEDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.0 Z$ q6 F* _0 c: L
n* p" i: \: RThe agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."& c. |9 b& s$ O) J s" o2 I
. M8 c7 H; {+ g% I, ?8 T
The APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.1 e9 Z: d! F! {4 _# p; a
7 |1 s; y, w( ^( WIt should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.( p4 e+ [& j/ o% @' ]
3 i1 m+ q$ w) B# dIt certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.# S* u& e, Z9 R& V
0 a) f; u( e7 ~5 r2 Y% t G8 U$ ?
"As a scientist, it's one of the highlights of my CAREER," Shan said.9 }4 ~( Z2 v6 p; l4 b; _7 b; S; H
5 L2 a2 t3 e+ J6 i4 `" x/ C- P2 t
"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."
2 }/ A- w# ?1 n* a3 E1 T' y! d" C# D( ?! _) a H- S& |8 g( t
It's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.
, i4 O1 k$ g o7 Z& v! t: `; i" F X3 s( n3 c1 C
Ginseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.
1 T+ ?- K$ }) {: B
4 k$ u0 h! I' F( S- y1 a, C- K! cThe approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.8 S D# b- t; D& N; R
% z. ~, b( d% i7 a; u) t7 h3 V5 N+ j( m
* p0 ~4 \7 ]9 q9 K' g
http://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|